Reduced Dose Bolus Alteplase vs Conventional Alteplase Infusion for Pulmonary Embolism Thrombolysis
- 1 September 1994
- journal article
- clinical trial
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 106 (3), 718-724
- https://doi.org/10.1378/chest.106.3.718
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionThe Lancet, 1993
- Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolismThe American Journal of Cardiology, 1992
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJournal of the American College of Cardiology, 1992
- Intracranial hemorrhage after rt-pa and heparin for acute myocardial infarction — The TIMI II pilot and randomized trial combined experienceJournal of the American College of Cardiology, 1990
- RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISMThe Lancet, 1988
- Perspectives on Treatment of Acute Pulmonary Embolism with Tissue Plasminogen ActivatorSeminars in Thrombosis and Hemostasis, 1987
- Design and analysis of group sequential tests based on the type I error spending rate functionBiometrika, 1987
- ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATORThe Lancet, 1986
- Group sequential methods for clinical trials with a one-sided hypothesisBiometrika, 1980
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957